Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Mollen John T, Director. Director active across 2 companies, notably ALEXION PHARMACEUTICALS, INC.. Cumulatively, 2 filings have been published. History available since 20 May 2021. The latest transaction was disclosed on 21 July 2021 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
John T. Mollen is a Board Member at Alexion Pharmaceuticals, Inc., a company committed to developing therapies for rare diseases. As a board member, he contributes to the governance and strategy of the company. His experience in the pharmaceutical sector is valuable for Alexion in its mission to improve patients' lives.